Psychological predictors of chemotherapy-induced nausea in women with breast cancer: Expectancies and perceived susceptibility.
chemotherapy
expect
nausea
nocebo
path analysis
susceptibility
Journal
European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
revised:
21
01
2021
received:
25
03
2020
accepted:
15
06
2021
pubmed:
30
7
2021
medline:
12
11
2021
entrez:
29
7
2021
Statut:
ppublish
Résumé
Chemotherapy-induced nausea is challenging to predict and treat. Research indicates that pretreatment psychological variables including patients' perceptions of their susceptibility to nausea, expectancies of treatment-related nausea and nausea history (i.e., motion sickness, morning sickness and baseline levels of nausea) may aid in predicting nausea severity during chemotherapy. However, this research is dated and limited in quantity. We investigated whether psychological variables could improve prediction of nausea severity to inform interventions targeting chemotherapy-induced nausea. In this secondary analysis, a subgroup of women receiving chemotherapy (for the first time) for breast cancer completed pretreatment measures: perceived nausea susceptibility, nausea expectancies, nausea history and baseline nausea. They rated subsequent nausea severity across 4-days, during treatment and posttreatment in a self-report diary. Structural Equation Modelling was used to explore associations. Across the women (N = 481), perceived nausea susceptibility predicted subsequent nausea severity (β = 0.16), but nausea expectancies did not (β = 0.05). Nausea history variables demonstrated small-moderate associations with perceived susceptibility (β = 0.21-0.32) and negligible-small associations with nausea expectancies (β = 0.07-0.14). Perceived nausea susceptibility appears to capture patients' nausea history, to a degree, and is related to nausea severity during treatment. This is an important variable to include in pretreatment prediction of patients at risk of severe nausea.
Identifiants
pubmed: 34323340
doi: 10.1111/ecc.13488
pmc: PMC9022467
mid: NIHMS1767549
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Pagination
e13488Subventions
Organisme : NCI NIH HHS
ID : R25 CA102618
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA102618
Pays : United States
Organisme : NCI NIH HHS
ID : UG1 CA189961
Pays : United States
Informations de copyright
© 2021 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd.
Références
Support Care Cancer. 2014 Oct;22(10):2749-56
pubmed: 24805911
Health Psychol. 2004 Jul;23(4):381-7
pubmed: 15264974
Eur J Pharmacol. 2014 Jan 5;722:172-9
pubmed: 24157982
Res Q Exerc Sport. 1997 Mar;68(1):44-55
pubmed: 9094762
Eur J Cancer Care (Engl). 2021 Nov;30(6):e13488
pubmed: 34323340
J Natl Cancer Inst. 2001 Jun 6;93(11):810-23
pubmed: 11390531
J Clin Psychol Med Settings. 2018 Dec;25(4):335-355
pubmed: 29480435
J Adv Pract Oncol. 2015 Jan-Feb;6(1):54-6
pubmed: 26413374
J Pain Symptom Manage. 2014 May;47(5):839-848.e4
pubmed: 24075401
N Engl J Med. 2016 Apr 7;374(14):1356-67
pubmed: 27050207
Cancer. 2005 Oct 15;104(8):1772-8
pubmed: 16116608
Front Pharmacol. 2019 Apr 25;10:410
pubmed: 31133847
Support Care Cancer. 2010 Jul;18(7):869-76
pubmed: 19701781
Ann Oncol. 2016 Sep;27(suppl 5):v119-v133
pubmed: 27664248
Cancer. 2004 Dec 1;101(11):2701-8
pubmed: 15517574
Ann Behav Med. 2003 Winter;25(1):48-54
pubmed: 12581936
J Pain Symptom Manage. 2012 Nov;44(5):692-703
pubmed: 22672920
J Health Psychol. 2018 Jan;23(1):3-16
pubmed: 27708126
Eur J Cancer Care (Engl). 2017 Mar;26(2):
pubmed: 28004440
J Clin Oncol. 2003 Nov 15;21(22):4112-9
pubmed: 14559886
Support Care Cancer. 2017 Apr;25(4):1271-1278
pubmed: 27995318
Eur J Pharmacol. 2014 Jan 5;722:192-6
pubmed: 24157977
Cancer. 2004 Aug 15;101(4):851-7
pubmed: 15305419
Ann Oncol. 2010 May;21 Suppl 5:v232-43
pubmed: 20555089
J Pain Symptom Manage. 2008 Apr;35(4):381-7
pubmed: 18243641
Support Care Cancer. 2013 Oct;21(10):2759-67
pubmed: 23715816
Ann Behav Med. 2010 Aug;40(1):3-14
pubmed: 20387022
Eur J Cancer Care (Engl). 2008 Sep;17(5):444-53
pubmed: 18637116
Cancer. 1985 Jun 15;55(12):2766-70
pubmed: 3995485
J Pain Symptom Manage. 2018 Sep;56(3):352-362
pubmed: 29857180
J Pain Symptom Manage. 2017 Aug;54(2):245-258.e2
pubmed: 28533160
Support Care Cancer. 2002 Mar;10(2):96-105
pubmed: 11862499
Support Care Cancer. 2015 Jan;23(1):283-91
pubmed: 25112561
Br J Math Stat Psychol. 1984 May;37 ( Pt 1):62-83
pubmed: 6733054
Support Care Cancer. 2016 Jun;24(6):2661-7
pubmed: 26768436
Expert Opin Drug Saf. 2014 Feb;13(2):139-50
pubmed: 24073801
J Clin Oncol. 2012 Sep 20;30(27):3389-95
pubmed: 22915657
Annu Rev Psychol. 2019 Jan 4;70:599-625
pubmed: 30110575
J Pain Symptom Manage. 2009 Nov;38(5):775-84
pubmed: 19775863